NYSE · MCK
Healthcare · Medical - Distribution
$893.39
Up+$2.88 (+0.32%)
Updated Aug 31, 2026, 12:06 AM
SID Score
6.6/10
Composite research score
Smart Money
50/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
MCK closed at $893.39 after 20 trading sessions, up 8.01% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $895.04 | $900.22 | $890.795 | $893.39 | 606.05K |
| Aug 27, 2026 | $889.27 | $891.95 | $880.77 | $890.51 | 1.11M |
| Aug 26, 2026 | $905.54 | $918.00 | $891.9939 | $896.65 | 1.06M |
| Aug 25, 2026 | $871.40 | $905.66 | $869.365 | $905.09 | 882.58K |
| Aug 24, 2026 | $861.47 | $875.64 | $859.75 | $873.79 | 600.5K |
| Aug 21, 2026 | $839.84 | $867.915 | $837.8801 | $858.90 | 1.58M |
| Aug 20, 2026 | $850.00 | $858.68 | $838.71 | $838.75 | 557.69K |
| Aug 19, 2026 | $864.22 | $869.99 | $850.01 | $853.71 | 938.78K |
| Aug 18, 2026 | $870.23 | $886.14 | $867.65 | $869.26 | 618.72K |
| Aug 17, 2026 | $859.49 | $879.335 | $855.93 | $859.92 | 1.14M |
| Aug 14, 2026 | $859.74 | $869.79 | $852.99 | $869.00 | 614.39K |
| Aug 13, 2026 | $873.09 | $875.46 | $856.69 | $856.69 | 992.5K |
| Aug 12, 2026 | $901.90 | $901.975 | $873.35 | $878.73 | 1.1M |
| Aug 11, 2026 | $877.33 | $902.05 | $877.33 | $901.77 | 805.02K |
| Aug 10, 2026 | $873.04 | $894.74 | $870.465 | $879.87 | 809.86K |
| Aug 7, 2026 | $864.34 | $889.69 | $864.32 | $869.58 | 1.56M |
| Aug 6, 2026 | $912.19 | $912.50 | $840.00 | $871.38 | 1.61M |
| Aug 5, 2026 | $840.40 | $879.48 | $840.40 | $877.23 | 1.14M |
| Aug 4, 2026 | $815.985 | $835.95 | $810.88 | $830.43 | 1.09M |
| Aug 3, 2026 | $858.55 | $863.08 | $822.65 | $827.14 | 1.47M |
The latest Smart Investors Daily articles mentioning MCK.
MCK research
Company profile and research snapshot.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | Barclays | Overweight | — |
| Aug 19, 2026 | RBC Capital | Sector Perform | — |
| Aug 11, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
| Aug 6, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 27, 2026
McKesson (NYSE:MCK) has outperformed the market over the past 10 years by 3.54% on an annualized basis producing an average annual return of 17.04%. Currently, McKesson has a market capitalization of $103.82 billion.
Benzinga · Aug 25, 2026
McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.
Yahoo · Aug 21, 2026
McKesson stock has delivered a very strong 336.0% return over the past five years, yet the current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) model both still point to the shares trading below their estimated worth. Over 5 years, McKesson has returned 336.0%, which puts recent share price moves in the context of a long and very strong run. Expectations for McKesson's ability to keep converting revenue into reliable cash flows can support the...
Yahoo · Aug 20, 2026
McKesson (MCK) is in focus after its technology leadership team joined the 17th Annual Atlanta C-Level Technology Leadership Summit, highlighting how its healthcare technology services fit alongside recent quarterly results and the current stock performance. See our latest analysis for McKesson. At a share price of $853.71, McKesson has eased slightly in the very short term, with a 1-day share price return that declined 1.79% and a 7-day share price return that declined 2.85%. However, its...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MCK.
